Because drug companies have focused on wealthy, white, Caucasian European markets, where individuals can pay the money and where they can draw clinical trial subjects from, research has been too dominated by white populations.

Because drug companies have focused on wealthy, white, Caucasian European markets, where individuals can pay the money and where they can draw clinical trial subjects from, research has been too dominated by white populations.: http://bit.ly/2U7ISc9 Read more... http://bit.ly/2Dq5mj5